Austin Westerling
Partner at Granite Point Capital
Greater Boston
Skills
Education
Work Experience
Partner
2012
Long / short public hedge and venture capital funds
2022
Investor
2022
Series B investor in e-commerce business revolutionizing the post purchase experience.
2020
Investor
2020
Series C investor in spend and expense management software platform. Acquired by Bill.com (NYSE: BILL) for $2.5B.
Investor
2018
Series A investor in pharmaceutical start-up developing therapies for central nervous system disorders using FDA-approved drug delivery technologies
2018
Investor
2018
Series C investor in one of the leading US multi-state operators in medical cannabis prior to IPO (ticker: ACRG). Pending acquisition by Canopy Growth (ticker: CGC) for $3.4B.
2018
Board Member
2018
Seed and lead Series A investor / director in SaaS business enabling direct-to-consumer brands to accelerate revenue growth and optimize profitability
Investor
2018
Series A investor in clinical stage pharma company dedicated to improving the lives of patients living with uncontrolled neurological diseases with an initial focus on refractory epilepsy
2018
Investor
2018
Seed investor in MIT start-up pioneering tRNA-based gene therapies to treat severe genetic diseases not amenable to traditional types of gene therapy.
2017
Investor
2017
Series A investor in one of leading global medical cannabis companies (Nasdaq: TLRY)
2017
Investor
2017
Series A investor in pain and wellness consumer products company using scientifically-formulated products